Mannavola D, Coco P, Vannucchi G, Bertuelli R, Carletto M, Casali PG, Beck-Peccoz P, Fugazzola L
Liraglutide was associated with a 0.23 percentage point decline in HbA1c ( P = .017), a 52.6 mg/g drop in urine albumin-to-creatine ratio ( P = .007) and a 0.25 mmol/L reduction in LDL cholesterol ( P = .02) from drug initiation to 1 year
When you start to get between that 7% to 10% range, then we see more significant benefits in MASH resolution (inflammation and scarring)
Advancing research will undoubtedly add to this outstanding list of benefits
People often worry about medications when they affect things like blood flow, inflammation, or hormones
These therapies offer a new horizon for patients who have struggled with traditional weight loss methods